Cold Chain Products Market for Plasma Fractionation by Type (Ultra-low temperature freezer, Plasma freezer, Temperature monitoring devices, Plasma contact shock freezer, Blood transport boxes, Ice-lined refrigerator), End User - Global Forecast to 2027
The global market for cold chain products in plasma fractionation is estimated to grow significantly. By 2027, it is projected to reach a value of USD 711 million, showing a compound annual growth rate (CAGR) of 4.5% during the forecast period, starting from USD 569 million in 2022. The expansion of the cold chain products market is driven by various factors, including increasing concerns regarding zoonotic diseases, growing utilization of immunoglobulins and other plasma products in diverse therapeutic areas, and a rising demand for plasma-derived medicinal products. The industry for cold chain products is expected to progress due to the increasing need for plasma freezers and other cold chain products, as well as the adoption of advanced cold storage devices. These advancements in technology contribute to the overall growth and development of the cold chain products sector.
“Ultra-low temperature freezer segment was dominated by the highest share in Cold Chain Products Market for Plasma Fractionation” The market for Cold Chain Products for Plasma Fractionation is divided into seven types such as Ultra-low temperature freezer, Plasma freezer, Temperature monitoring devices, Plasma contact shock freezer, Blood transport boxes, Ice-lined refrigerator, and Others. The Ultra-low temperature freezer segment accounted for the highest share of the global Cold Chain Products for Plasma Fractionation in 2021. Increasing Demand for Plasma-Derived Medicinal Products, Advancements in Plasma Fractionation Technologies, and Growing Need for Cold Chain Infrastructure all some of the factors that are anticipated to promote market expansion throughout the projected period.
'Blood collection centers and blood component providers accounted for the fastest growing segment of the Cold Chain Products Market for Plasma Fractionation in 2021.'
The Cold Chain Products Market for Plasma Fractionation is divided into Blood collection centers and blood component providers, Hospitals and transfusion centers, Clinical research laboratories, and Others based on end users. In 2021, Blood collection centers and blood component providers held the highest market share for cold chain products for plasma fractionation. Growing demand for plasma fractionation, rising awareness and screening for blood-borne diseases, and expansion of healthcare infrastructure are some of the factors that contribute to the big proportion of this market.
'Latin America is expected to witness the fastest growth in the forecast period.' In the forecast period, Latin America in the Cold Chain Products Market for Plasma Fractionation will have the fastest rising regional growth. Large number of hospitals and healthcare facilities, increasing spread of chronic diseases such as immune deficiencies, hemophilia, and autoimmune disorders are the main factors driving market growth. The rise of these illnesses in Latin America has resulted in a higher requirement for plasma freezers and refrigerators to preserve vital medical resources. In response to growing healthcare needs, advancements in medical treatments, and a growing understanding of the advantages of plasma-based products, the plasma fractionation sector in Latin America has been expanding. This expansion drives the need for suitable storage devices, such as plasma freezers and refrigerators.
Following is a list of the major players (supply-side) in the Cold Chain Products Market for Plasma Fractionation that this study refers to: By Company Type: Tier 1- 34%, Tier 2- 46%, and Tier 3- 20% By Designation: C-level- 35%, Director Level—25%, and Others- 40% By Region: North America-30%, Europe-45%, Asia Pacific-20%, Latin America- 3%, and Middle East and Africa-2% Several of the major companies in the market for Cold Chain Products for Plasma Fractionation include B Medical Systems (US), Blue Star Limited (India), Thermo Fisher Scientific (US), Godrej and Boyce Manufacturing Co. Ltd. (India), Haier Biomedical (China), Eppendorf SE (Germany), Avantor, Inc. (US), Biolife Solutions Inc. (US), and Helmer Scientific Inc. (US)
Research Coverage:
The market study analyzes the main market segments for cold chain products. The objective of this study is to estimate the market's size and growth potential across several categories according to type, end user, and region. The report also provides a thorough competition analysis of the major market participants, together with company profiles, major insights regarding their product and service offerings, recent advancements, and key market strategies.
Key Benefits of Buying the Report:
The study provides data regarding the cold chain products market's closest approximations and its segments, which will benefit market leaders and new entrants. This study will assist stakeholders in comprehending the competitive environment, obtaining insights to better position of their businesses, and developing appropriate go-to-market strategies. The research will also assist stakeholders in obtaining insights into the market's pulse and learning about its major drivers, inhibitors, opportunities, and problems.
The report provides insights on the following pointers:
Analysis of key drivers (Rising use of immunoglobulins and other plasma products in a range of therapeutic area, Increasing demand for Plasma-derived medicinal products, and Technological advancements in refrigeration equipment and systems), opportunities (Demand for Plasma Fractionation Centre and Government support for cold chain infrastructure development), and challenges (Shortage of trained manpower & limited resources to maintain the equipment, Stringent government regulations, and Environmental concerns regarding greenhouse gas emissions) influencing the growth of the Cold Chain Products Market for Plasma Fractionation.
Product Development/innovation:
Comprehensive details on new technologies, R&D initiatives, and product and service launches for Cold Chain Products Market for Plasma Fractionation
Market Development:
Comprehensive data on attractive markets, and the research analyzes the global Cold Chain Products Market for Plasma Fractionation
Market Diversification:
Detailed information on emerging products and services, unexplored regions, current trends, and investments in the Cold Chain Products Market for Plasma Fractionation.
Competitive Assessment:
Comprehensive analysis of market shares, growth plans, and service offerings of major companies operating in the Cold Chain Products Market for Plasma Fractionation like B Medical Systems (US), Blue Star Limited (India), Thermo Fisher Scientific (US), Godrej and Boyce Manufacturing Co. Ltd. (India), Haier Biomedical (China), Eppendorf SE (Germany), Avantor, Inc. (US), Biolife Solutions Inc. (US), and Helmer Scientific Inc. (US)
“Ultra-low temperature freezer segment was dominated by the highest share in Cold Chain Products Market for Plasma Fractionation” The market for Cold Chain Products for Plasma Fractionation is divided into seven types such as Ultra-low temperature freezer, Plasma freezer, Temperature monitoring devices, Plasma contact shock freezer, Blood transport boxes, Ice-lined refrigerator, and Others. The Ultra-low temperature freezer segment accounted for the highest share of the global Cold Chain Products for Plasma Fractionation in 2021. Increasing Demand for Plasma-Derived Medicinal Products, Advancements in Plasma Fractionation Technologies, and Growing Need for Cold Chain Infrastructure all some of the factors that are anticipated to promote market expansion throughout the projected period.
'Blood collection centers and blood component providers accounted for the fastest growing segment of the Cold Chain Products Market for Plasma Fractionation in 2021.'
The Cold Chain Products Market for Plasma Fractionation is divided into Blood collection centers and blood component providers, Hospitals and transfusion centers, Clinical research laboratories, and Others based on end users. In 2021, Blood collection centers and blood component providers held the highest market share for cold chain products for plasma fractionation. Growing demand for plasma fractionation, rising awareness and screening for blood-borne diseases, and expansion of healthcare infrastructure are some of the factors that contribute to the big proportion of this market.
'Latin America is expected to witness the fastest growth in the forecast period.' In the forecast period, Latin America in the Cold Chain Products Market for Plasma Fractionation will have the fastest rising regional growth. Large number of hospitals and healthcare facilities, increasing spread of chronic diseases such as immune deficiencies, hemophilia, and autoimmune disorders are the main factors driving market growth. The rise of these illnesses in Latin America has resulted in a higher requirement for plasma freezers and refrigerators to preserve vital medical resources. In response to growing healthcare needs, advancements in medical treatments, and a growing understanding of the advantages of plasma-based products, the plasma fractionation sector in Latin America has been expanding. This expansion drives the need for suitable storage devices, such as plasma freezers and refrigerators.
Following is a list of the major players (supply-side) in the Cold Chain Products Market for Plasma Fractionation that this study refers to: By Company Type: Tier 1- 34%, Tier 2- 46%, and Tier 3- 20% By Designation: C-level- 35%, Director Level—25%, and Others- 40% By Region: North America-30%, Europe-45%, Asia Pacific-20%, Latin America- 3%, and Middle East and Africa-2% Several of the major companies in the market for Cold Chain Products for Plasma Fractionation include B Medical Systems (US), Blue Star Limited (India), Thermo Fisher Scientific (US), Godrej and Boyce Manufacturing Co. Ltd. (India), Haier Biomedical (China), Eppendorf SE (Germany), Avantor, Inc. (US), Biolife Solutions Inc. (US), and Helmer Scientific Inc. (US)
Research Coverage:
The market study analyzes the main market segments for cold chain products. The objective of this study is to estimate the market's size and growth potential across several categories according to type, end user, and region. The report also provides a thorough competition analysis of the major market participants, together with company profiles, major insights regarding their product and service offerings, recent advancements, and key market strategies.
Key Benefits of Buying the Report:
The study provides data regarding the cold chain products market's closest approximations and its segments, which will benefit market leaders and new entrants. This study will assist stakeholders in comprehending the competitive environment, obtaining insights to better position of their businesses, and developing appropriate go-to-market strategies. The research will also assist stakeholders in obtaining insights into the market's pulse and learning about its major drivers, inhibitors, opportunities, and problems.
The report provides insights on the following pointers:
Analysis of key drivers (Rising use of immunoglobulins and other plasma products in a range of therapeutic area, Increasing demand for Plasma-derived medicinal products, and Technological advancements in refrigeration equipment and systems), opportunities (Demand for Plasma Fractionation Centre and Government support for cold chain infrastructure development), and challenges (Shortage of trained manpower & limited resources to maintain the equipment, Stringent government regulations, and Environmental concerns regarding greenhouse gas emissions) influencing the growth of the Cold Chain Products Market for Plasma Fractionation.
Product Development/innovation:
Comprehensive details on new technologies, R&D initiatives, and product and service launches for Cold Chain Products Market for Plasma Fractionation
Market Development:
Comprehensive data on attractive markets, and the research analyzes the global Cold Chain Products Market for Plasma Fractionation
Market Diversification:
Detailed information on emerging products and services, unexplored regions, current trends, and investments in the Cold Chain Products Market for Plasma Fractionation.
Competitive Assessment:
Comprehensive analysis of market shares, growth plans, and service offerings of major companies operating in the Cold Chain Products Market for Plasma Fractionation like B Medical Systems (US), Blue Star Limited (India), Thermo Fisher Scientific (US), Godrej and Boyce Manufacturing Co. Ltd. (India), Haier Biomedical (China), Eppendorf SE (Germany), Avantor, Inc. (US), Biolife Solutions Inc. (US), and Helmer Scientific Inc. (US)
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKET SCOPE
FIGURE 1 COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION SEGMENTATION
FIGURE 2 COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY REGION
1.3.1 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH APPROACH
FIGURE 3 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
FIGURE 4 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
FIGURE 6 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 7 REVENUE SHARE ANALYSIS ILLUSTRATION: THERMO FISHER SCIENTIFIC (US)
FIGURE 8 SUPPLY-SIDE ANALYSIS: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION (2021)
FIGURE 9 COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION: BOTTOM-UP APPROACH
FIGURE 10 DRIVERS, OPPORTUNITIES, AND CHALLENGES (2022–2027): IMPACT ON MARKET GROWTH AND CAGR
FIGURE 11 CAGR PROJECTIONS
FIGURE 12 TOP-DOWN APPROACH
2.3 LIMITATIONS
2.3.1 METHODOLOGY-RELATED LIMITATIONS
2.3.2 MARKET BREAKDOWN & DATA TRIANGULATION
FIGURE 13 MARKET DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ANALYSIS
2.5 STUDY ASSUMPTIONS
2.6 RISK ASSESSMENT
2.7 RECESSION IMPACT ANALYSIS
3 EXECUTIVE SUMMARY
FIGURE 14 COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2022 VS. 2027 (USD MILLION)
FIGURE 15 COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2022 VS. 2027 (USD MILLION)
FIGURE 16 COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION: GEOGRAPHIC SNAPSHOT
4 PREMIUM INSIGHTS
4.1 COLD CHAIN PRODUCTS FOR PLASMA FRACTIONATION: MARKET OVERVIEW
FIGURE 17 RISING USE OF IMMUNOGLOBULINS AND OTHER PLASMA PRODUCTS TO DRIVE MARKET GROWTH
4.2 ASIA PACIFIC: COLD CHAIN PRODUCTS FOR PLASMA FRACTIONATION, BY TYPE & COUNTRY (2021)
FIGURE 18 ULTRA-LOW-TEMPERATURE FREEZERS TO HOLD LARGEST MARKET SHARE
4.3 COLD CHAIN PRODUCTS FOR PLASMA FRACTIONATION: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 19 CHINA TO REGISTER HIGHEST GROWTH OVER FORECAST PERIOD
4.4 COLD CHAIN PRODUCTS FOR PLASMA FRACTIONATION: GEOGRAPHIC MIX
FIGURE 20 NORTH AMERICA TO DOMINATE MARKET OVER FORECAST PERIOD
4.5 COLD CHAIN PRODUCTS FOR PLASMA FRACTIONATION: DEVELOPING VS. DEVELOPED COUNTRIES
FIGURE 21 DEVELOPING COUNTRIES TO PRESENT GROWTH OPPORTUNITIES TO MARKET PLAYERS DURING THE FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 22 COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Rising use of immunoglobulins and other plasma products
FIGURE 23 WORLDWIDE POLYVALENT IMMUNE GLOBULIN SALES FROM 2010 TO 2026
5.2.1.2 Increasing demand for plasma-derived medicinal products to treat chronic diseases
TABLE 1 PLASMA-DERIVED MEDICINAL PRODUCTS AND THEIR CLINICAL INDICATIONS
5.2.1.3 Technological advancements in refrigeration equipment and systems
5.2.2 OPPORTUNITIES
5.2.2.1 Demand for plasma fractionation centers
FIGURE 24 PLASMA FRACTIONATION PLANTS WORLDWIDE (2018)
5.2.2.2 Government support for cold chain infrastructure development
5.2.3 CHALLENGES
5.2.3.1 Shortage of trained manpower and limited resources to maintain equipment
5.2.3.2 Stringent government regulations
5.2.3.3 Environmental concerns regarding greenhouse gas emissions
5.3 PRICING ANALYSIS
5.3.1 AVERAGE SELLING PRICE OF COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE
TABLE 2 AVERAGE SELLING PRICE OF COLD CHAIN PRODUCTS, BY TYPE (USD)
5.3.2 AVERAGE SELLING PRICE TRENDS
5.4 SUPPLY CHAIN ANALYSIS
FIGURE 25 SUPPLY CHAIN ANALYSIS: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION
5.5 ECOSYSTEM ANALYSIS
FIGURE 26 ECOSYSTEM ANALYSIS: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION
5.6 PATENT ANALYSIS
FIGURE 27 PATENT PUBLICATION TRENDS (JANUARY 2013–MARCH 2023)
FIGURE 28 TOP APPLICANTS (COMPANIES/INSTITUTES) FOR COLD CHAIN PRODUCTS FOR PLASMA FRACTIONATION PATENTS (2013–2023)
5.7 VALUE CHAIN ANALYSIS
FIGURE 29 VALUE CHAIN ANALYSIS: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION
5.8 TECHNOLOGY ANALYSIS
5.8.1 KEY TECHNOLOGY
5.8.1.1 Ultra-low freezer technology
5.8.2 ADJACENT TECHNOLOGY
5.8.2.1 Cryopreservation
5.9 REGULATORY LANDSCAPE
5.9.1 REGULATORY ANALYSIS
5.9.1.1 North America
5.9.1.2 Europe
5.9.1.3 Asia Pacific
5.9.1.4 Latin America
5.9.1.5 Middle East and Africa
5.9.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATION
TABLE 3 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 4 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 5 ASIA PACIFIC AND ROW: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.10 PORTER’S FIVE FORCES ANALYSIS
TABLE 6 PORTER’S FIVE FORCES ANALYSIS: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION
5.10.1 INTENSITY OF COMPETITIVE RIVALRY
5.10.2 BARGAINING POWER OF SUPPLIERS
5.10.3 BARGAINING POWER OF BUYERS
5.10.4 THREAT OF NEW ENTRANTS
5.10.5 THREAT OF SUBSTITUTES
5.11 KEY CONFERENCES AND EVENTS, 2023–2024
TABLE 7 COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION: KEY CONFERENCES AND EVENTS, 2023–2024
5.12 KEY STAKEHOLDERS AND BUYING CRITERIA
5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 30 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF COLD CHAIN PRODUCTS FOR PLASMA FRACTIONATION
TABLE 8 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE TYPES OF COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION
5.12.2 BUYING CRITERIA
TABLE 9 KEY BUYING CRITERIA FOR TOP THREE TYPES OF COLD CHAIN PRODUCTS FOR PLASMA FRACTIONATION
5.13 TRADE ANALYSIS
TABLE 10 EXPORTS OF COLD CHAIN STORAGE LABORATORY EQUIPMENT (2022)
TABLE 11 IMPORTS OF COLD CHAIN STORAGE LABORATORY EQUIPMENT (2022)
5.14 COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION: RECESSION IMPACT
6 COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE
6.1 INTRODUCTION
TABLE 12 COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)
TABLE 13 COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY COUNTRY, 2020–2027 (USD MILLION)
6.2 ULTRA-LOW-TEMPERATURE FREEZERS
6.2.1 RISING DEMAND IN PLASMA STORAGE APPLICATIONS TO DRIVE MARKET GROWTH
TABLE 14 ULTRA-LOW-TEMPERATURE FREEZERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.3 PLASMA FREEZERS
6.3.1 RISING DEMAND IN SCIENTIFIC AND THERAPEUTIC APPLICATIONS TO BOOST GROWTH
TABLE 15 PLASMA FREEZERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.4 TEMPERATURE MONITORING DEVICES
6.4.1 ADOPTION OF NOVEL TECHNOLOGIES IN TEMPERATURE MONITORING DEVICES TO PROPEL MARKET
TABLE 16 TEMPERATURE MONITORING DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.5 PLASMA CONTACT SHOCK FREEZERS
6.5.1 NEED FOR RAPID FREEZING IN PLASMA TRANSPORT TO DRIVE MARKET
TABLE 17 PLASMA CONTACT SHOCK FREEZERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.6 BLOOD TRANSPORT BOXES
6.6.1 RISING ADOPTION OF TEMPERATURE-CONTROLLED BOXES TO TRANSPORT PLASMA FRACTIONATED COMPOUNDS TO DRIVE MARKET
TABLE 18 BLOOD TRANSPORT BOXES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.7 ICE-LINED REFRIGERATORS
6.7.1 COST-EFFECTIVENESS TO PROPEL END-USER ADOPTION
TABLE 19 ICE-LINED REFRIGERATORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.8 OTHER PRODUCTS
TABLE 20 OTHER COLD CHAIN PRODUCTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7 COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER
7.1 INTRODUCTION
TABLE 21 COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)
7.2 BLOOD COLLECTION CENTERS & BLOOD COMPONENT PROVIDERS
7.2.1 RISING DEMAND FOR PLASMA-DERIVED PRODUCTS TO DRIVE MARKET GROWTH
TABLE 22 COLD CHAIN PRODUCTS MARKET FOR BLOOD COLLECTION CENTERS & BLOOD COMPONENT PROVIDERS, BY COUNTRY, 2020–2027 (USD MILLION)
7.3 HOSPITALS & TRANSFUSION CENTERS
7.3.1 NEED TO ENSURE SAFE COLLECTION, STORAGE, AND COLD CHAIN MANAGEMENT OF PLASMA TO DRIVE MARKET GROWTH
TABLE 23 COLD CHAIN PRODUCTS MARKET FOR HOSPITALS & TRANSFUSION CENTERS, BY COUNTRY, 2020–2027 (USD MILLION)
7.4 CLINICAL RESEARCH LABORATORIES
7.4.1 ROLE OF LABS IN PLASMA FRACTIONATION AND COLD CHAIN PRODUCT DEVELOPMENT TO BOOST MARKET GROWTH
TABLE 24 COLD CHAIN PRODUCTS MARKET FOR CLINICAL RESEARCH LABORATORIES, BY COUNTRY, 2020–2027 (USD MILLION)
7.5 OTHER END USERS
TABLE 25 COLD CHAIN PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2020–2027 (USD MILLION)
8 COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY REGION
8.1 INTRODUCTION
FIGURE 31 COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION: GEOGRAPHIC GROWTH OPPORTUNITIES
TABLE 26 COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY REGION, 2020–2027 (USD MILLION)
8.2 NORTH AMERICA
8.2.1 NORTH AMERICA: RECESSION IMPACT
FIGURE 32 NORTH AMERICA: LABORATORY FREEZERS MARKET SNAPSHOT
TABLE 27 NORTH AMERICA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 28 NORTH AMERICA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)
TABLE 29 NORTH AMERICA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)
8.2.2 US
8.2.2.1 US to hold largest share of North American market
TABLE 30 US: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)
TABLE 31 US: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)
8.2.3 CANADA
8.2.3.1 Growing pharma R&D and increasing use of plasma-derived compounds to boost market
TABLE 32 CANADA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)
TABLE 33 CANADA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)
8.3 EUROPE
8.3.1 EUROPE: RECESSION IMPACT
TABLE 34 EUROPE: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 35 EUROPE: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)
TABLE 36 EUROPE: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)
8.3.2 GERMANY
8.3.2.1 Germany to dominate European market
TABLE 37 GERMANY: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)
TABLE 38 GERMANY: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)
8.3.3 FRANCE
8.3.3.1 Growing biotech & pharma industry and high prevalence of bleeding disorders to drive market
TABLE 39 FRANCE: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)
TABLE 40 FRANCE: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)
8.3.4 UK
8.3.4.1 Rising incidence of hemophilia and growing consumption of coagulation factors to propel market
TABLE 41 UK: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)
TABLE 42 UK: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)
8.3.5 ITALY
8.3.5.1 Strong pharma sector and rising geriatric population to support market
TABLE 43 ITALY: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)
TABLE 44 ITALY: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)
8.3.6 SPAIN
8.3.6.1 Rising chronic disease prevalence to boost demand
TABLE 45 SPAIN: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)
TABLE 46 SPAIN: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)
8.3.7 REST OF EUROPE
TABLE 47 REST OF EUROPE: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)
TABLE 48 REST OF EUROPE: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)
8.4 ASIA PACIFIC
8.4.1 ASIA PACIFIC: RECESSION IMPACT
FIGURE 33 APAC: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION SNAPSHOT
TABLE 49 ASIA PACIFIC: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 50 ASIA PACIFIC: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)
TABLE 51 ASIA PACIFIC: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)
8.4.2 CHINA
8.4.2.1 China to dominate Asia Pacific market
TABLE 52 CHINA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)
TABLE 53 CHINA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)
8.4.3 JAPAN
8.4.3.1 Growing aging population and rising prevalence of neurological disorders to propel growth
TABLE 54 JAPAN: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)
TABLE 55 JAPAN: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)
8.4.4 INDIA
8.4.4.1 Growing pharma-biotech industry to drive demand
TABLE 56 INDIA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)
TABLE 57 INDIA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)
8.4.5 SOUTH KOREA
8.4.5.1 Rising awareness, advancements in medical treatments, and aging population to drive market
TABLE 58 SOUTH KOREA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)
TABLE 59 SOUTH KOREA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)
8.4.6 AUSTRALIA
8.4.6.1 Rising demand for plasma products to treat chronic diseases to propel market
TABLE 60 AUSTRALIA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)
TABLE 61 AUSTRALIA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)
8.4.7 REST OF ASIA PACIFIC
TABLE 62 REST OF ASIA PACIFIC: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)
TABLE 63 REST OF ASIA PACIFIC: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)
8.5 LATIN AMERICA
8.5.1 RISING INVESTMENTS IN BRAZIL AND GROWING DISEASE PREVALENCE ACROSS LATAM TO BOOST MARKET
8.5.2 LATIN AMERICA: RECESSION IMPACT
TABLE 64 LATIN AMERICA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)
TABLE 65 LATIN AMERICA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)
8.6 MIDDLE EAST & AFRICA
8.6.1 INFRASTRUCTURAL DEVELOPMENT IN HEALTHCARE TO OFFER GROWTH OPPORTUNITIES
8.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT
TABLE 66 MIDDLE EAST & AFRICA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)
TABLE 67 MIDDLE EAST & AFRICA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)
9 COMPETITIVE LANDSCAPE
9.1 OVERVIEW
9.2 KEY PLAYER STRATEGIES
TABLE 68 OVERVIEW OF STRATEGIES ADOPTED BY MAJOR PLAYERS IN COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION
9.3 REVENUE SHARE ANALYSIS FOR KEY PLAYERS IN COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION
FIGURE 34 REVENUE ANALYSIS FOR KEY PLAYERS IN COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION MARKET
9.4 MARKET SHARE ANALYSIS
FIGURE 35 COLD CHAIN PRODUCTS FOR PLASMA FRACTIONATION: MARKET SHARE ANALYSIS, BY KEY PLAYER, 2021
TABLE 69 COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION: DEGREE OF COMPETITION
FIGURE 36 R&D ASSESSMENT OF KEY PLAYERS
9.5 COMPANY EVALUATION QUADRANT (KEY COMPANIES), 2021
9.5.1 STARS
9.5.2 PERVASIVE PLAYERS
9.5.3 EMERGING LEADERS
9.5.4 PARTICIPANTS
FIGURE 37 COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION: COMPANY EVALUATION MATRIX, 2021
9.6 COMPETITIVE BENCHMARKING
TABLE 70 OVERALL COMPANY FOOTPRINT
TABLE 71 COMPANY FOOTPRINT ANALYSIS, BY TYPE
TABLE 72 COMPANY FOOTPRINT ANALYSIS, BY END USER
TABLE 73 COMPANY FOOTPRINT ANALYSIS, BY REGION
9.7 COMPETITIVE SCENARIO
9.7.1 PRODUCT LAUNCHES & APPROVALS
TABLE 74 PRODUCT LAUNCHES & APPROVALS, JANUARY 2019–MARCH 2023
9.7.2 DEALS
TABLE 75 DEALS, JANUARY 2021–MARCH 2023
9.7.3 OTHER DEVELOPMENTS
TABLE 76 OTHER DEVELOPMENTS, JANUARY 2019– MARCH 2023
10 COMPANY PROFILES
(Business overview, Products offered, Recent Developments, MNM view)*
10.1 KEY PLAYERS
10.1.1 THERMO FISHER SCIENTIFIC, INC.
TABLE 77 THERMO FISHER SCIENTIFIC: BUSINESS OVERVIEW
FIGURE 38 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT
10.1.2 HAIER BIOMEDICAL (HAIER GROUP)
TABLE 78 HAIER BIOMEDICAL: BUSINESS OVERVIEW
FIGURE 39 HAIER BIOMEDICAL (HAIER GROUP): COMPANY SNAPSHOT (2021)
10.1.3 EPPENDORF SE
TABLE 79 EPPENDORF AG: BUSINESS OVERVIEW
FIGURE 40 EPPENDORF AG: COMPANY SNAPSHOT
10.1.4 B MEDICAL SYSTEMS (AZENTA)
TABLE 80 B. MEDICAL SYSTEM (AZENTA): BUSINESS OVERVIEW
FIGURE 41 B MEDICAL SYSTEMS (AZENTA): COMPANY SNAPSHOT (2021)
10.1.5 BLUE STAR LIMITED
TABLE 81 BLUE STAR LIMITED: BUSINESS OVERVIEW
FIGURE 42 BLUE STAR LIMITED: COMPANY SNAPSHOT
TABLE 82 BLUE STAR LIMITED: PRODUCTS OFFERED
10.1.6 AVANTOR, INC.
TABLE 83 AVANTOR, INC.: BUSINESS OVERVIEW
FIGURE 43 AVANTOR, INC.: COMPANY SNAPSHOT
10.1.7 GODREJ AND BOYCE MANUFACTURING CO. LTD.
TABLE 84 GODREJ AND BOYCE MANUFACTURING CO. LTD.: BUSINESS OVERVIEW
FIGURE 44 GODREJ AND BOYCE MANUFACTURING CO. LTD.: COMPANY SNAPSHOT
10.1.8 BIOLIFE SOLUTIONS
TABLE 85 BIOLIFE SOLUTIONS: BUSINESS OVERVIEW
FIGURE 45 BIOLIFE SOLUTIONS: COMPANY SNAPSHOT
10.1.9 HELMER SCIENTIFIC
TABLE 86 HELMER SCIENTIFIC: BUSINESS OVERVIEW
10.1.10 VESTFROST SOLUTIONS A/S
TABLE 87 VESTFROST SOLUTIONS A/S: BUSINESS OVERVIEW
10.1.11 JEIO TECH INC.
TABLE 88 JEIO TECH INC.: BUSINESS OVERVIEW
10.1.12 DEEPEE COOLING PRODUCTS
TABLE 89 DEEPEE COOLING PRODUCTS: BUSINESS OVERVIEW
10.1.13 BERLINGER & CO. AG
TABLE 90 BERLINGER & CO. AG: BUSINESS OVERVIEW
10.1.14 MONNIT CORPORATION
TABLE 91 MONNIT CORPORATION: BUSINESS OVERVIEW
10.1.15 ZHEJIANG HELI REFRIGERATION EQUIPMENT CO. LTD.
TABLE 92 ZHEJIANG HELI REFRIGERATION EQUIPMENT CO. LTD.: BUSINESS OVERVIEW
*Details on Business overview, Products offered, Recent Developments, MNM view might not be captured in case of unlisted companies.
10.2 OTHER PLAYERS
10.2.1 QINGDAO CAREBIOS BIOLOGICAL TECHNOLOGY CO., LTD
10.2.2 EBAC CO., LTD.
10.2.3 BIOTECNO
10.2.4 ZHONGKE MEILING CRYOGENICS CO., LTD.
10.2.5 BIONICS SCIENTIFIC TECHNOLOGIES (P) LTD.
10.2.6 STERICOX INDIA PRIVATE LIMITED
10.2.7 ENVIRO TECHNOLOGIES
10.2.8 WITHNELL SENSORS
10.2.9 TECNOSOFT SRL
10.2.10 PHILIPP KIRSCH GMBH
11 APPENDIX
11.1 DISCUSSION GUIDE
11.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
11.3 RELATED REPORTS
11.4 AUTHOR DETAILS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKET SCOPE
FIGURE 1 COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION SEGMENTATION
FIGURE 2 COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY REGION
1.3.1 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH APPROACH
FIGURE 3 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
FIGURE 4 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
FIGURE 6 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 7 REVENUE SHARE ANALYSIS ILLUSTRATION: THERMO FISHER SCIENTIFIC (US)
FIGURE 8 SUPPLY-SIDE ANALYSIS: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION (2021)
FIGURE 9 COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION: BOTTOM-UP APPROACH
FIGURE 10 DRIVERS, OPPORTUNITIES, AND CHALLENGES (2022–2027): IMPACT ON MARKET GROWTH AND CAGR
FIGURE 11 CAGR PROJECTIONS
FIGURE 12 TOP-DOWN APPROACH
2.3 LIMITATIONS
2.3.1 METHODOLOGY-RELATED LIMITATIONS
2.3.2 MARKET BREAKDOWN & DATA TRIANGULATION
FIGURE 13 MARKET DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ANALYSIS
2.5 STUDY ASSUMPTIONS
2.6 RISK ASSESSMENT
2.7 RECESSION IMPACT ANALYSIS
3 EXECUTIVE SUMMARY
FIGURE 14 COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2022 VS. 2027 (USD MILLION)
FIGURE 15 COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2022 VS. 2027 (USD MILLION)
FIGURE 16 COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION: GEOGRAPHIC SNAPSHOT
4 PREMIUM INSIGHTS
4.1 COLD CHAIN PRODUCTS FOR PLASMA FRACTIONATION: MARKET OVERVIEW
FIGURE 17 RISING USE OF IMMUNOGLOBULINS AND OTHER PLASMA PRODUCTS TO DRIVE MARKET GROWTH
4.2 ASIA PACIFIC: COLD CHAIN PRODUCTS FOR PLASMA FRACTIONATION, BY TYPE & COUNTRY (2021)
FIGURE 18 ULTRA-LOW-TEMPERATURE FREEZERS TO HOLD LARGEST MARKET SHARE
4.3 COLD CHAIN PRODUCTS FOR PLASMA FRACTIONATION: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 19 CHINA TO REGISTER HIGHEST GROWTH OVER FORECAST PERIOD
4.4 COLD CHAIN PRODUCTS FOR PLASMA FRACTIONATION: GEOGRAPHIC MIX
FIGURE 20 NORTH AMERICA TO DOMINATE MARKET OVER FORECAST PERIOD
4.5 COLD CHAIN PRODUCTS FOR PLASMA FRACTIONATION: DEVELOPING VS. DEVELOPED COUNTRIES
FIGURE 21 DEVELOPING COUNTRIES TO PRESENT GROWTH OPPORTUNITIES TO MARKET PLAYERS DURING THE FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 22 COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Rising use of immunoglobulins and other plasma products
FIGURE 23 WORLDWIDE POLYVALENT IMMUNE GLOBULIN SALES FROM 2010 TO 2026
5.2.1.2 Increasing demand for plasma-derived medicinal products to treat chronic diseases
TABLE 1 PLASMA-DERIVED MEDICINAL PRODUCTS AND THEIR CLINICAL INDICATIONS
5.2.1.3 Technological advancements in refrigeration equipment and systems
5.2.2 OPPORTUNITIES
5.2.2.1 Demand for plasma fractionation centers
FIGURE 24 PLASMA FRACTIONATION PLANTS WORLDWIDE (2018)
5.2.2.2 Government support for cold chain infrastructure development
5.2.3 CHALLENGES
5.2.3.1 Shortage of trained manpower and limited resources to maintain equipment
5.2.3.2 Stringent government regulations
5.2.3.3 Environmental concerns regarding greenhouse gas emissions
5.3 PRICING ANALYSIS
5.3.1 AVERAGE SELLING PRICE OF COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE
TABLE 2 AVERAGE SELLING PRICE OF COLD CHAIN PRODUCTS, BY TYPE (USD)
5.3.2 AVERAGE SELLING PRICE TRENDS
5.4 SUPPLY CHAIN ANALYSIS
FIGURE 25 SUPPLY CHAIN ANALYSIS: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION
5.5 ECOSYSTEM ANALYSIS
FIGURE 26 ECOSYSTEM ANALYSIS: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION
5.6 PATENT ANALYSIS
FIGURE 27 PATENT PUBLICATION TRENDS (JANUARY 2013–MARCH 2023)
FIGURE 28 TOP APPLICANTS (COMPANIES/INSTITUTES) FOR COLD CHAIN PRODUCTS FOR PLASMA FRACTIONATION PATENTS (2013–2023)
5.7 VALUE CHAIN ANALYSIS
FIGURE 29 VALUE CHAIN ANALYSIS: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION
5.8 TECHNOLOGY ANALYSIS
5.8.1 KEY TECHNOLOGY
5.8.1.1 Ultra-low freezer technology
5.8.2 ADJACENT TECHNOLOGY
5.8.2.1 Cryopreservation
5.9 REGULATORY LANDSCAPE
5.9.1 REGULATORY ANALYSIS
5.9.1.1 North America
5.9.1.2 Europe
5.9.1.3 Asia Pacific
5.9.1.4 Latin America
5.9.1.5 Middle East and Africa
5.9.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATION
TABLE 3 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 4 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 5 ASIA PACIFIC AND ROW: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.10 PORTER’S FIVE FORCES ANALYSIS
TABLE 6 PORTER’S FIVE FORCES ANALYSIS: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION
5.10.1 INTENSITY OF COMPETITIVE RIVALRY
5.10.2 BARGAINING POWER OF SUPPLIERS
5.10.3 BARGAINING POWER OF BUYERS
5.10.4 THREAT OF NEW ENTRANTS
5.10.5 THREAT OF SUBSTITUTES
5.11 KEY CONFERENCES AND EVENTS, 2023–2024
TABLE 7 COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION: KEY CONFERENCES AND EVENTS, 2023–2024
5.12 KEY STAKEHOLDERS AND BUYING CRITERIA
5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 30 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF COLD CHAIN PRODUCTS FOR PLASMA FRACTIONATION
TABLE 8 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE TYPES OF COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION
5.12.2 BUYING CRITERIA
TABLE 9 KEY BUYING CRITERIA FOR TOP THREE TYPES OF COLD CHAIN PRODUCTS FOR PLASMA FRACTIONATION
5.13 TRADE ANALYSIS
TABLE 10 EXPORTS OF COLD CHAIN STORAGE LABORATORY EQUIPMENT (2022)
TABLE 11 IMPORTS OF COLD CHAIN STORAGE LABORATORY EQUIPMENT (2022)
5.14 COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION: RECESSION IMPACT
6 COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE
6.1 INTRODUCTION
TABLE 12 COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)
TABLE 13 COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY COUNTRY, 2020–2027 (USD MILLION)
6.2 ULTRA-LOW-TEMPERATURE FREEZERS
6.2.1 RISING DEMAND IN PLASMA STORAGE APPLICATIONS TO DRIVE MARKET GROWTH
TABLE 14 ULTRA-LOW-TEMPERATURE FREEZERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.3 PLASMA FREEZERS
6.3.1 RISING DEMAND IN SCIENTIFIC AND THERAPEUTIC APPLICATIONS TO BOOST GROWTH
TABLE 15 PLASMA FREEZERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.4 TEMPERATURE MONITORING DEVICES
6.4.1 ADOPTION OF NOVEL TECHNOLOGIES IN TEMPERATURE MONITORING DEVICES TO PROPEL MARKET
TABLE 16 TEMPERATURE MONITORING DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.5 PLASMA CONTACT SHOCK FREEZERS
6.5.1 NEED FOR RAPID FREEZING IN PLASMA TRANSPORT TO DRIVE MARKET
TABLE 17 PLASMA CONTACT SHOCK FREEZERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.6 BLOOD TRANSPORT BOXES
6.6.1 RISING ADOPTION OF TEMPERATURE-CONTROLLED BOXES TO TRANSPORT PLASMA FRACTIONATED COMPOUNDS TO DRIVE MARKET
TABLE 18 BLOOD TRANSPORT BOXES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.7 ICE-LINED REFRIGERATORS
6.7.1 COST-EFFECTIVENESS TO PROPEL END-USER ADOPTION
TABLE 19 ICE-LINED REFRIGERATORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.8 OTHER PRODUCTS
TABLE 20 OTHER COLD CHAIN PRODUCTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7 COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER
7.1 INTRODUCTION
TABLE 21 COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)
7.2 BLOOD COLLECTION CENTERS & BLOOD COMPONENT PROVIDERS
7.2.1 RISING DEMAND FOR PLASMA-DERIVED PRODUCTS TO DRIVE MARKET GROWTH
TABLE 22 COLD CHAIN PRODUCTS MARKET FOR BLOOD COLLECTION CENTERS & BLOOD COMPONENT PROVIDERS, BY COUNTRY, 2020–2027 (USD MILLION)
7.3 HOSPITALS & TRANSFUSION CENTERS
7.3.1 NEED TO ENSURE SAFE COLLECTION, STORAGE, AND COLD CHAIN MANAGEMENT OF PLASMA TO DRIVE MARKET GROWTH
TABLE 23 COLD CHAIN PRODUCTS MARKET FOR HOSPITALS & TRANSFUSION CENTERS, BY COUNTRY, 2020–2027 (USD MILLION)
7.4 CLINICAL RESEARCH LABORATORIES
7.4.1 ROLE OF LABS IN PLASMA FRACTIONATION AND COLD CHAIN PRODUCT DEVELOPMENT TO BOOST MARKET GROWTH
TABLE 24 COLD CHAIN PRODUCTS MARKET FOR CLINICAL RESEARCH LABORATORIES, BY COUNTRY, 2020–2027 (USD MILLION)
7.5 OTHER END USERS
TABLE 25 COLD CHAIN PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2020–2027 (USD MILLION)
8 COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY REGION
8.1 INTRODUCTION
FIGURE 31 COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION: GEOGRAPHIC GROWTH OPPORTUNITIES
TABLE 26 COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY REGION, 2020–2027 (USD MILLION)
8.2 NORTH AMERICA
8.2.1 NORTH AMERICA: RECESSION IMPACT
FIGURE 32 NORTH AMERICA: LABORATORY FREEZERS MARKET SNAPSHOT
TABLE 27 NORTH AMERICA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 28 NORTH AMERICA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)
TABLE 29 NORTH AMERICA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)
8.2.2 US
8.2.2.1 US to hold largest share of North American market
TABLE 30 US: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)
TABLE 31 US: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)
8.2.3 CANADA
8.2.3.1 Growing pharma R&D and increasing use of plasma-derived compounds to boost market
TABLE 32 CANADA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)
TABLE 33 CANADA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)
8.3 EUROPE
8.3.1 EUROPE: RECESSION IMPACT
TABLE 34 EUROPE: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 35 EUROPE: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)
TABLE 36 EUROPE: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)
8.3.2 GERMANY
8.3.2.1 Germany to dominate European market
TABLE 37 GERMANY: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)
TABLE 38 GERMANY: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)
8.3.3 FRANCE
8.3.3.1 Growing biotech & pharma industry and high prevalence of bleeding disorders to drive market
TABLE 39 FRANCE: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)
TABLE 40 FRANCE: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)
8.3.4 UK
8.3.4.1 Rising incidence of hemophilia and growing consumption of coagulation factors to propel market
TABLE 41 UK: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)
TABLE 42 UK: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)
8.3.5 ITALY
8.3.5.1 Strong pharma sector and rising geriatric population to support market
TABLE 43 ITALY: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)
TABLE 44 ITALY: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)
8.3.6 SPAIN
8.3.6.1 Rising chronic disease prevalence to boost demand
TABLE 45 SPAIN: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)
TABLE 46 SPAIN: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)
8.3.7 REST OF EUROPE
TABLE 47 REST OF EUROPE: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)
TABLE 48 REST OF EUROPE: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)
8.4 ASIA PACIFIC
8.4.1 ASIA PACIFIC: RECESSION IMPACT
FIGURE 33 APAC: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION SNAPSHOT
TABLE 49 ASIA PACIFIC: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 50 ASIA PACIFIC: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)
TABLE 51 ASIA PACIFIC: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)
8.4.2 CHINA
8.4.2.1 China to dominate Asia Pacific market
TABLE 52 CHINA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)
TABLE 53 CHINA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)
8.4.3 JAPAN
8.4.3.1 Growing aging population and rising prevalence of neurological disorders to propel growth
TABLE 54 JAPAN: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)
TABLE 55 JAPAN: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)
8.4.4 INDIA
8.4.4.1 Growing pharma-biotech industry to drive demand
TABLE 56 INDIA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)
TABLE 57 INDIA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)
8.4.5 SOUTH KOREA
8.4.5.1 Rising awareness, advancements in medical treatments, and aging population to drive market
TABLE 58 SOUTH KOREA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)
TABLE 59 SOUTH KOREA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)
8.4.6 AUSTRALIA
8.4.6.1 Rising demand for plasma products to treat chronic diseases to propel market
TABLE 60 AUSTRALIA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)
TABLE 61 AUSTRALIA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)
8.4.7 REST OF ASIA PACIFIC
TABLE 62 REST OF ASIA PACIFIC: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)
TABLE 63 REST OF ASIA PACIFIC: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)
8.5 LATIN AMERICA
8.5.1 RISING INVESTMENTS IN BRAZIL AND GROWING DISEASE PREVALENCE ACROSS LATAM TO BOOST MARKET
8.5.2 LATIN AMERICA: RECESSION IMPACT
TABLE 64 LATIN AMERICA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)
TABLE 65 LATIN AMERICA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)
8.6 MIDDLE EAST & AFRICA
8.6.1 INFRASTRUCTURAL DEVELOPMENT IN HEALTHCARE TO OFFER GROWTH OPPORTUNITIES
8.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT
TABLE 66 MIDDLE EAST & AFRICA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)
TABLE 67 MIDDLE EAST & AFRICA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)
9 COMPETITIVE LANDSCAPE
9.1 OVERVIEW
9.2 KEY PLAYER STRATEGIES
TABLE 68 OVERVIEW OF STRATEGIES ADOPTED BY MAJOR PLAYERS IN COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION
9.3 REVENUE SHARE ANALYSIS FOR KEY PLAYERS IN COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION
FIGURE 34 REVENUE ANALYSIS FOR KEY PLAYERS IN COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION MARKET
9.4 MARKET SHARE ANALYSIS
FIGURE 35 COLD CHAIN PRODUCTS FOR PLASMA FRACTIONATION: MARKET SHARE ANALYSIS, BY KEY PLAYER, 2021
TABLE 69 COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION: DEGREE OF COMPETITION
FIGURE 36 R&D ASSESSMENT OF KEY PLAYERS
9.5 COMPANY EVALUATION QUADRANT (KEY COMPANIES), 2021
9.5.1 STARS
9.5.2 PERVASIVE PLAYERS
9.5.3 EMERGING LEADERS
9.5.4 PARTICIPANTS
FIGURE 37 COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION: COMPANY EVALUATION MATRIX, 2021
9.6 COMPETITIVE BENCHMARKING
TABLE 70 OVERALL COMPANY FOOTPRINT
TABLE 71 COMPANY FOOTPRINT ANALYSIS, BY TYPE
TABLE 72 COMPANY FOOTPRINT ANALYSIS, BY END USER
TABLE 73 COMPANY FOOTPRINT ANALYSIS, BY REGION
9.7 COMPETITIVE SCENARIO
9.7.1 PRODUCT LAUNCHES & APPROVALS
TABLE 74 PRODUCT LAUNCHES & APPROVALS, JANUARY 2019–MARCH 2023
9.7.2 DEALS
TABLE 75 DEALS, JANUARY 2021–MARCH 2023
9.7.3 OTHER DEVELOPMENTS
TABLE 76 OTHER DEVELOPMENTS, JANUARY 2019– MARCH 2023
10 COMPANY PROFILES
(Business overview, Products offered, Recent Developments, MNM view)*
10.1 KEY PLAYERS
10.1.1 THERMO FISHER SCIENTIFIC, INC.
TABLE 77 THERMO FISHER SCIENTIFIC: BUSINESS OVERVIEW
FIGURE 38 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT
10.1.2 HAIER BIOMEDICAL (HAIER GROUP)
TABLE 78 HAIER BIOMEDICAL: BUSINESS OVERVIEW
FIGURE 39 HAIER BIOMEDICAL (HAIER GROUP): COMPANY SNAPSHOT (2021)
10.1.3 EPPENDORF SE
TABLE 79 EPPENDORF AG: BUSINESS OVERVIEW
FIGURE 40 EPPENDORF AG: COMPANY SNAPSHOT
10.1.4 B MEDICAL SYSTEMS (AZENTA)
TABLE 80 B. MEDICAL SYSTEM (AZENTA): BUSINESS OVERVIEW
FIGURE 41 B MEDICAL SYSTEMS (AZENTA): COMPANY SNAPSHOT (2021)
10.1.5 BLUE STAR LIMITED
TABLE 81 BLUE STAR LIMITED: BUSINESS OVERVIEW
FIGURE 42 BLUE STAR LIMITED: COMPANY SNAPSHOT
TABLE 82 BLUE STAR LIMITED: PRODUCTS OFFERED
10.1.6 AVANTOR, INC.
TABLE 83 AVANTOR, INC.: BUSINESS OVERVIEW
FIGURE 43 AVANTOR, INC.: COMPANY SNAPSHOT
10.1.7 GODREJ AND BOYCE MANUFACTURING CO. LTD.
TABLE 84 GODREJ AND BOYCE MANUFACTURING CO. LTD.: BUSINESS OVERVIEW
FIGURE 44 GODREJ AND BOYCE MANUFACTURING CO. LTD.: COMPANY SNAPSHOT
10.1.8 BIOLIFE SOLUTIONS
TABLE 85 BIOLIFE SOLUTIONS: BUSINESS OVERVIEW
FIGURE 45 BIOLIFE SOLUTIONS: COMPANY SNAPSHOT
10.1.9 HELMER SCIENTIFIC
TABLE 86 HELMER SCIENTIFIC: BUSINESS OVERVIEW
10.1.10 VESTFROST SOLUTIONS A/S
TABLE 87 VESTFROST SOLUTIONS A/S: BUSINESS OVERVIEW
10.1.11 JEIO TECH INC.
TABLE 88 JEIO TECH INC.: BUSINESS OVERVIEW
10.1.12 DEEPEE COOLING PRODUCTS
TABLE 89 DEEPEE COOLING PRODUCTS: BUSINESS OVERVIEW
10.1.13 BERLINGER & CO. AG
TABLE 90 BERLINGER & CO. AG: BUSINESS OVERVIEW
10.1.14 MONNIT CORPORATION
TABLE 91 MONNIT CORPORATION: BUSINESS OVERVIEW
10.1.15 ZHEJIANG HELI REFRIGERATION EQUIPMENT CO. LTD.
TABLE 92 ZHEJIANG HELI REFRIGERATION EQUIPMENT CO. LTD.: BUSINESS OVERVIEW
*Details on Business overview, Products offered, Recent Developments, MNM view might not be captured in case of unlisted companies.
10.2 OTHER PLAYERS
10.2.1 QINGDAO CAREBIOS BIOLOGICAL TECHNOLOGY CO., LTD
10.2.2 EBAC CO., LTD.
10.2.3 BIOTECNO
10.2.4 ZHONGKE MEILING CRYOGENICS CO., LTD.
10.2.5 BIONICS SCIENTIFIC TECHNOLOGIES (P) LTD.
10.2.6 STERICOX INDIA PRIVATE LIMITED
10.2.7 ENVIRO TECHNOLOGIES
10.2.8 WITHNELL SENSORS
10.2.9 TECNOSOFT SRL
10.2.10 PHILIPP KIRSCH GMBH
11 APPENDIX
11.1 DISCUSSION GUIDE
11.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
11.3 RELATED REPORTS
11.4 AUTHOR DETAILS
